Table 4.

Treatment of Manifestations in Individuals with Pelizaeus-Merzbacher-Like Disease 1

ManifestationTreatmentConsiderations/Other
Developmental
delay & cognitive
dysfunction
Accommodations in special classroom setting or w/aideRecommendations from pediatric neurologist may be necessary to achieve maximum intellectual & functional abilities.
Spasticity Oral GABA agonists (e.g., baclofen, diazepam)For more focal spasticity, consider intramuscular injection of botulinum toxin.
Physical therapy
Use of equipment such as walker & wheelchair
Dystonia When associated w/spasticity, mgmt of dystonia w/baclofen or intramuscular botulinum toxin;
trihexyphenidyl or tetrabenazine potentially helpful
In many cases, dystonia is refractory to medical mgmt.
Scoliosis &
joint dislocation
Mgmt or surgical intervention by orthopedist
Swallowing
dysfunction
Consider swallowing eval & feeding therapyAffected individuals are at risk of aspiration.
Nutrition plan & possible supportive feeding device to avoid malnutrition
Dysarthria Consider speech therapy to improve communication abilitiesAugmentative communication approaches are often necessary.
Seizures Standard antiepileptic drug therapy
Hearing loss Standard approaches to hearing loss incl augmentative communication approaches; no evidence exists for cochlear implants in this contextSee Hereditary Hearing Loss and Deafness Overview.
Optic atrophy Supportive approaches for the vision-impaired individual

From: Pelizaeus-Merzbacher-Like Disease 1

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2025.
Copyright © 1993-2025, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2025 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.